Compare, Analyse Elder Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ELDER PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
ADCOCK INGRAM
Jun-14
ELDER PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs380349-   
Low Rs188252-   
Sales per share (Unadj.) Rs491.2103.7-  
Earnings per share (Unadj.) Rs-3.2-26.1-  
Cash flow per share (Unadj.) Rs14.4-21.7-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs376.581.4-  
Shares outstanding (eoy) m20.54168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.62.9 20.0%   
Avg P/E ratio x-89.3-11.5 777.4%  
P/CF ratio (eoy) x19.7-13.9 -142.3%  
Price / Book Value ratio x0.83.7 20.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,83350,658 11.5%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m2,1793,179 68.5%   
Avg. sales/employee Rs ThNM4,078.4-  
Avg. wages/employee Rs ThNM740.6-  
Avg. net profit/employee Rs ThNM-1,027.7-  
INCOME DATA
Net Sales Rs m10,08917,508 57.6%  
Other income Rs m257123 209.3%   
Total revenues Rs m10,34617,631 58.7%   
Gross profit Rs m-792-3,034 26.1%  
Depreciation Rs m361756 47.8%   
Interest Rs m2,756474 581.2%   
Profit before tax Rs m-3,653-4,141 88.2%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m125259 48.4%   
Profit after tax Rs m-65-4,412 1.5%  
Gross profit margin %-7.8-17.3 45.3%  
Effective tax rate %-3.4-6.2 54.8%   
Net profit margin %-0.6-25.2 2.6%  
BALANCE SHEET DATA
Current assets Rs m9,24012,823 72.1%   
Current liabilities Rs m9,9987,215 138.6%   
Net working cap to sales %-7.532.0 -23.4%  
Current ratio x0.91.8 52.0%  
Inventory Days Days46111 41.8%  
Debtors Days Days60124 48.4%  
Net fixed assets Rs m10,1247,475 135.4%   
Share capital Rs m20681 253.0%   
"Free" reserves Rs m5,5820-   
Net worth Rs m7,73413,742 56.3%   
Long term debt Rs m4,8894,829 101.2%   
Total assets Rs m22,88225,960 88.1%  
Interest coverage x-0.3-7.7 4.2%   
Debt to equity ratio x0.60.4 179.9%  
Sales to assets ratio x0.40.7 65.4%   
Return on assets %11.8-15.2 -77.5%  
Return on equity %-0.8-32.1 2.6%  
Return on capital %22.3-19.8 -112.6%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Net fx Rs m1810-   
CASH FLOW
From Operations Rs m11,7541,494 786.5%  
From Investments Rs m-561-459 122.1%  
From Financial Activity Rs m-6,7624,383 -154.3%  
Net Cashflow Rs m4,4325,418 81.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.81 Rs / ZAR

Compare ELDER PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ELDER PHARMA With: SANOFI INDIA  FRESENIUS KABI ONCO.  DR. DATSONS LABS  FULFORD INDIA  PIRAMAL ENTERPRISES  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - GLENMARK PHARMA COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS